KMID : 0357920100440040390
|
|
Korean Journal of Pathology 2010 Volume.44 No. 4 p.390 ~ p.396
|
|
Clinicopathological Significance of Invasive Ductal Carcinoma with High Prevalence of CD44+/CD24-/low Tumor Cells in Breast Cancer
|
|
Sung Ji-Youn
Kim Gou-Young Park Yong-Koo Lee Ju-Hie Kim Youn-Hwa Lim Sung-Jig
|
|
Abstract
|
|
|
Background: Epithelial tumor cells with a CD44+/CD24-/low immunoprofile may have the ability to cause breast cancer. We studied these cells and their clinicopathological significance.
Methods: The clinicopathologic findings of 100 invasive ductal carcinoma (IDC) cases and 45 ductal carcinoma in situ (DCIS) cases were reviewed. CD44+/CD24-/low tumor cells were identified by immunohistochemistry, and their clinicopathological implications in IDC and DCIS were analyzed.
Results: IDC with a high prevalence of CD44+/CD24-/low tumor cells was significantly associated with larger mass, higher grade, estrogen receptor (ER) negativity, and tumor cells with a higher frequency of metastasis. The proportion of CD44+/CD24-/low tumor cells in IDC, and its DCIS components was not significantly different, whereas the proportion of CD44+/CD24-/low tumor cells was higher in DCIS than in the DCIS component of IDC (p < 0.001).
Conclusions: IDC with a high prevalence of CD44+/CD24-/low tumor cells might correlate with aggressive features, such as ER and higher grades. Moreover, the proportion of CD44+/CD24-/low tumor cells in the DCIS components of IDC and DCIS might harbor different biology, which may lead to differences in cancer progression and early carcinogenesis.
|
|
KEYWORD
|
|
Neoplastic stem cells, CD44 protein, human, CD24 protein, human, Invasive ductal carcinoma, Carcinoma, intraductal, noninfiltrating
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|